HCA Healthcare, Inc. 8-K

What Happened HCA Healthcare, Inc. announced preliminary results of operations for the second quarter ended June 30, 2026 in a press release issued July 14, 2026. The company filed an 8-K reporting these results under Item 2.02 (Results of Operations and Financial Condition) and disclosed the same release under Item 7.01 (Regulation FD Disclosure). The text of the press release is included as Exhibit 99.1 to the filing. The report is signed by Michael A. Marks, Executive Vice President and Chief Financial Officer.

Key Details

• Filing date: July 14, 2026 (Form 8-K).
• Period reported: Preliminary results for the quarter ended June 30, 2026 (Q2 2026).
• Items reported: Item 2.02 (results) and Item 7.01 (Regulation FD disclosure).
• Exhibit: Press release included as Exhibit 99.1.

Why It Matters This 8-K signals that HCA has publicly released preliminary quarterly results, which may include key earnings, revenue, or operating updates (see the press release for specifics). The Regulation FD disclosure ensures the information was broadly disseminated to investors at the same time. Retail investors should review the Exhibit 99.1 press release for the reported figures and monitor subsequent SEC filings (e.g., Form 10-Q) for audited details and additional context.